Patents by Inventor Laurene Wang

Laurene Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING OPERATIVE COMPLICATIONS OF CATARACT SURGERY
    Publication number: 20240366631
    Abstract: The present disclosure provides a method of treating or ameliorating an operative complication of a cataract surgery. The method comprises administering nanoparticles of clobetasol propionate to a subject in need thereof.
    Type: Application
    Filed: May 1, 2023
    Publication date: November 7, 2024
    Applicant: FORMOSA PHARMACEUTICALS, INC.
    Inventors: Chen Yu CHENG, Laurene WANG, Wei-Cheng LIAW, Derek Joseph Raphael NUNEZ
  • PEPTIDES WITH ANTIMICROBIAL ACTIVITIES
    Publication number: 20240360177
    Abstract: The disclosure includes peptides of Formula (I): S1-[block-1]m-x-[block-2]n-y-[block-3]o-z-[block-4]p-S2. Also included are pharmaceutical compositions containing the peptides and methods of treating microbial infections using the peptides.
    Type: Application
    Filed: September 1, 2022
    Publication date: October 31, 2024
    Inventors: Laurene Wang, David E. Pereira, Dale J. . Christensen, Kara S. Keedy, Gregory J. Pacofsky, Derek J. Nunez
  • FORMULATIONS OF L-ORNITHINE PHENYLACETATE
    Publication number: 20220202755
    Abstract: Some embodiments of the present application are directed to oral formulations of L-ornithine phenylacetate and methods of using the same. These oral formulations offer alternative administration route than the standard intravenous administration of L-ornithine phenylacetate for treating hyperammonemia in patients having various acute and chronic liver diseases and disorders, for example, acute liver failure, liver cirrhosis, liver decompensation, portal hypertension, hepatic encephalopathy, or patients with urea cycle disorders.
    Type: Application
    Filed: January 6, 2022
    Publication date: June 30, 2022
    Inventors: Laurene Wang, Stanley Bukofzer, Linda S. Grais
  • FORMULATIONS OF L-ORNITHINE PHENYLACETATE
    Publication number: 20220184014
    Abstract: Some embodiments of the present application are directed to oral formulations of L-ornithine phenylacetate and methods of preparing the same. These oral formulations offer alternative administration route than the standard intravenous administration of L-ornithine phenylacetate for treating hyperammonemia in patients having various acute and chronic liver diseases and disorders, for example, acute liver failure, liver cirrhosis, liver decompensation, portal hypertension, hepatic encephalopathy, or patients with urea cycle disorders.
    Type: Application
    Filed: December 22, 2021
    Publication date: June 16, 2022
    Inventors: Kenneth Ruettimann, Mark Coffin, James Bernstein, Gary Goodson, Laurene Wang
  • Formulations of L-ornithine phenylacetate
    Patent number: 11219611
    Abstract: Some embodiments of the present application are directed to oral formulations of L-ornithine phenylacetate and methods of using the same. These oral formulations offer alternative administration route than the standard intravenous administration of L-ornithine phenylacetate for treating hyperammonemia in patients having various acute and chronic liver diseases and disorders, for example, acute liver failure, liver cirrhosis, liver decompensation, portal hypertension, hepatic encephalopathy, or patients with urea cycle disorders.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: January 11, 2022
    Assignee: Ocera Therapeutics, Inc.
    Inventors: Laurene Wang, Stanley Bukofzer, Linda S. Grais
  • FORMULATIONS OF L-ORNITHINE PHENYLACETATE
    Publication number: 20170135973
    Abstract: Some embodiments of the present application are directed to oral formulations of L-ornithine phenylacetate and methods of using the same. These oral formulations offer alternative administration route than the standard intravenous administration of L-ornithine phenylacetate for treating hyperammonemia in patients having various acute and chronic liver diseases and disorders, for example, acute liver failure, liver cirrhosis, liver decompensation, portal hypertension, hepatic encephalopathy, or patients with urea cycle disorders.
    Type: Application
    Filed: November 11, 2016
    Publication date: May 18, 2017
    Inventors: Laurene Wang, Stan Bukofzer, Linda S. Grais
  • FORMULATIONS OF L-ORNITHINE PHENYLACETATE
    Publication number: 20160338982
    Abstract: Some embodiments of the present application are directed to oral formulations of L-ornithine phenylacetate and methods of preparing the same. These oral formulations offer alternative administration route than the standard intravenous administration of L-ornithine phenylacetate for treating hyperammonemia in patients having various acute and chronic liver diseases and disorders, for example, acute liver failure, liver cirrhosis, liver decompensation, portal hypertension, hepatic encephalopathy, or patients with urea cycle disorders.
    Type: Application
    Filed: April 19, 2016
    Publication date: November 24, 2016
    Inventors: Kenneth Ruettimann, Mark Coffin, James Bernstein, Gary Goodson, Laurene Wang